Steven Bellon
2022
In 2022, Steven Bellon earned a total compensation of $2.1M as Chief Scientific Officer at Foghorn Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $130,500 |
|---|---|
| Option Awards | $1,580,167 |
| Salary | $435,000 |
| Total | $2,145,667 |
Bellon received $1.6M in option awards, accounting for 74% of the total pay in 2022.
Bellon also received $130.5K in non-equity incentive plan and $435K in salary.
Rankings
In 2022, Steven Bellon's compensation ranked 1,661st out of 5,756 executives tracked by ExecPay. In other words, Bellon earned more than 71.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,661 out of 5,756 | 71st |
Division Manufacturing | 863 out of 3,133 | 73rd |
Major group Chemicals And Allied Products | 342 out of 1,419 | 76th |
Industry group Drugs | 316 out of 1,320 | 76th |
Industry Pharmaceutical Preparations | 226 out of 966 | 77th |
Source: SEC filing on May 3, 2024.
Bellon's colleagues
We found one more compensation record of an executive who worked with Steven Bellon at Foghorn Therapeutics in 2022.
2022
Adrian Gottschalk
Foghorn Therapeutics